Latest Revenue Generation News

Jade Gas Holdings has raised A$5 million through a placement to advance commercial gas production at its Red Lake field, with a follow-up Share Purchase Plan aiming to raise an additional A$2.1 million.

Bannerman Energy Ltd reported a robust cash position of AUD 111.76 million at the end of September 2025, underpinning an estimated 13.5 quarters of operational funding despite ongoing exploration expenditures.

Compumedics has secured a $2.15 million placement to fast-track commercialisation of its Somfit D device following early FDA approval, positioning the company for significant growth in the US home sleep testing market.

Auric Mining has begun processing high-grade ore from its Munda Starter Pit earlier than planned, with first gold sales expected this month and cash flow anticipated by November.

Wellard Limited has received a final Australian Taxation Office ruling confirming its recent 15 cents-per-share return of capital is not taxable as a dividend, clarifying the tax implications for shareholders following the sale of its last revenue-generating asset.

Wellard Limited has formally requested to delist from the ASX following the sale of its final revenue-generating vessel, aiming to reduce costs and return excess cash to shareholders. The move awaits shareholder approval at the upcoming AGM.

Bravura Solutions has raised its FY26 revenue and cash EBITDA guidance, citing a strong British pound and increased project activity in EMEA as key growth drivers.

Altech Batteries has partnered with AMPower to immediately market and distribute sodium nickel chloride batteries across Europe, Australia, and the USA, fast-tracking revenue ahead of its large-scale CERENERGY project in Germany.

New Murchison Gold Limited has reported a robust start to production at its Crown Prince Gold Mine, with significant ore processed and first revenue expected in October 2025.

Anteris Technologies has gained shareholder approval for an ASX waiver allowing flexible capital raising and updated its PARADIGM trial timeline, now set to begin patient enrolment in Q4 2025 after addressing FDA requests.

Lefroy Exploration has received the first $1.25 million cash advance from BML Ventures, strengthening its financial position ahead of key development milestones at the Lucky Strike and Burns Central gold projects.

Renergen Limited forecasts a significant increase in its loss per share for the six months ending August 2025, driven by one-off transaction expenses and full commissioning costs of its Phase 1 plant.